In addition, it was also found that T-box transcription factor TBX1, which targets microRNA-6727-5p, inhibits cervical cancer cell growth and enhances cisplatin chemosensitivity through the AKT and MAPK pathways [27]. Here, AKT1 is linked to cervical cancer.